{"id":31704,"date":"2025-07-22T15:22:32","date_gmt":"2025-07-22T15:22:32","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/es\/?page_id=31704"},"modified":"2025-07-30T11:05:10","modified_gmt":"2025-07-30T11:05:10","slug":"estado-de-informacion-no-financiera","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera","title":{"rendered":"Estado de informaci\u00f3n no financiera"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"31704\" class=\"elementor elementor-31704\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-197548c9 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"197548c9\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3899e7ea\" data-id=\"3899e7ea\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-2d15555a elementor-widget elementor-widget-text-editor\" data-id=\"2d15555a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>(Estado de informaci\u00f3n no financiera &#8211; EINF)<\/p><p>Con el objetivo de cumplir con la Ley 11\/2018 de informaci\u00f3n no financiera y diversidad, anualmente Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora su Estado de informaci\u00f3n no financiera, siguiendo las recomendaciones e indicaciones dispuestas por la citada Ley 11\/2018.<\/p><p>El informe incluye informaci\u00f3n sobre cuestiones ambientales, sociales y de personal, derechos humanos, lucha contra la corrupci\u00f3n y el soborno e impacto de la organizaci\u00f3n en la sociedad. Para cada uno de los asuntos, se describen las pol\u00edticas y acciones desarrolladas, as\u00ed como los riesgos identificados y derivados del desarrollo de la actividad de la empresa. El informe se ha preparado conforme a los principios de comparabilidad, fiabilidad, materialidad y relevancia establecidos en la citada Ley 11\/2018.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-4b86092d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"4b86092d\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-7a0ee416\" data-id=\"7a0ee416\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-de3132b elementor-widget elementor-widget-button\" data-id=\"de3132b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2025\/07\/30110325\/informe-de-verificacion-einf-neuraxpharm-pharmaceuticals-s-l-u-2024.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Estado de informaci\u00f3n no financiera 2024<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-d7431aa elementor-widget elementor-widget-button\" data-id=\"d7431aa\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131305\/informe-einf-neuraxpharm-pharmaceuticals-2023.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Estado de informaci\u00f3n no financiera 2023<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-7a89ea6b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7a89ea6b\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-527ffc02\" data-id=\"527ffc02\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-382bc26c elementor-widget elementor-widget-button\" data-id=\"382bc26c\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131248\/informe-einf-laboratorios-lesvi-2022.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Estado de informaci\u00f3n no financiera 2022<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-76feba1d elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"76feba1d\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-4e39e10\" data-id=\"4e39e10\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d21d16a elementor-widget elementor-widget-button\" data-id=\"d21d16a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/2025\/04\/30131241\/informe-einf-laboratorios-lesvi-2021.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Estado de informaci\u00f3n no financiera 2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>(Estado de informaci\u00f3n no financiera &#8211; EINF) Con el objetivo de cumplir con la Ley 11\/2018 de informaci\u00f3n no financiera y diversidad, anualmente Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora su Estado de informaci\u00f3n no financiera, siguiendo las recomendaciones e indicaciones dispuestas por la citada Ley 11\/2018. El informe incluye informaci\u00f3n sobre cuestiones ambientales, [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-31704","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Estado de informaci\u00f3n no financiera - Neuraxpharm Espa\u00f1a<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estado de informaci\u00f3n no financiera\" \/>\n<meta property=\"og:description\" content=\"(Estado de informaci\u00f3n no financiera &#8211; EINF) Con el objetivo de cumplir con la Ley 11\/2018 de informaci\u00f3n no financiera y diversidad, anualmente Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora su Estado de informaci\u00f3n no financiera, siguiendo las recomendaciones e indicaciones dispuestas por la citada Ley 11\/2018. El informe incluye informaci\u00f3n sobre cuestiones ambientales, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm Espa\u00f1a\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-30T11:05:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/04\/neuraxpharm-your-cns-specialist.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1779\" \/>\n\t<meta property=\"og:image:height\" content=\"995\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera\",\"name\":\"Estado de informaci\u00f3n no financiera - Neuraxpharm Espa\u00f1a\",\"isPartOf\":{\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\"},\"datePublished\":\"2025-07-22T15:22:32+00:00\",\"dateModified\":\"2025-07-30T11:05:10+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.neuraxpharm.com\/es\/#website\",\"url\":\"https:\/\/www.neuraxpharm.com\/es\/\",\"name\":\"Neuraxpharm Espa\u00f1a\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Estado de informaci\u00f3n no financiera - Neuraxpharm Espa\u00f1a","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera","og_locale":"es_ES","og_type":"article","og_title":"Estado de informaci\u00f3n no financiera","og_description":"(Estado de informaci\u00f3n no financiera &#8211; EINF) Con el objetivo de cumplir con la Ley 11\/2018 de informaci\u00f3n no financiera y diversidad, anualmente Neuraxpharm Pharmaceuticals S.L.U. (anteriormente Laboratorios Lesvi S.L.U.) elabora su Estado de informaci\u00f3n no financiera, siguiendo las recomendaciones e indicaciones dispuestas por la citada Ley 11\/2018. El informe incluye informaci\u00f3n sobre cuestiones ambientales, [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera","og_site_name":"Neuraxpharm Espa\u00f1a","article_modified_time":"2025-07-30T11:05:10+00:00","og_image":[{"width":1779,"height":995,"url":"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/8\/2021\/04\/neuraxpharm-your-cns-specialist.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera","url":"https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera","name":"Estado de informaci\u00f3n no financiera - Neuraxpharm Espa\u00f1a","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/es\/#website"},"datePublished":"2025-07-22T15:22:32+00:00","dateModified":"2025-07-30T11:05:10+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/es\/estado-de-informacion-no-financiera"]}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/es\/#website","url":"https:\/\/www.neuraxpharm.com\/es\/","name":"Neuraxpharm Espa\u00f1a","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/pages\/31704","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/comments?post=31704"}],"version-history":[{"count":10,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/pages\/31704\/revisions"}],"predecessor-version":[{"id":31933,"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/pages\/31704\/revisions\/31933"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/es\/wp-json\/wp\/v2\/media?parent=31704"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}